| Literature DB >> 24500561 |
Fang Wang1, Andrea Wan1, Brian Rodrigues2.
Abstract
Heparan sulfate proteoglycans are ubiquitous glycoproteins that contain several heparan sulfate polysaccharide side chains attached to a core protein. They function not only as a primary structural component of the extracellular matrix, but also provide a storage depot for bioactive molecules, such as basic fibroblast growth factor, vascular endothelial growth factor and lipoprotein lipase. Heparanase is an endoglycosidase that specifically hydrolyzes heparan sulfate into oligosaccharides. Recent studies have indicated that heparanase is engaged in the initiation and progression of diabetes, in addition to its associated complications. This review focuses on the participation of heparanase in the cleavage of heparan sulfate proteoglycans in pancreatic islets promoting beta cell death, promotion of atherosclerosis, and its role in cardiac metabolic switching in the early stage of cardiomyopathy during diabetes. Understanding the mechanisms by which heparanase is regulated in diabetes could provide a drug target to prevent diabetes and its complications.Entities:
Keywords: cardiomyopathie; cardiomyopathy; diabetes; diabète; heparanase; héparanase
Mesh:
Substances:
Year: 2013 PMID: 24500561 DOI: 10.1016/j.jcjd.2013.05.008
Source DB: PubMed Journal: Can J Diabetes ISSN: 1499-2671 Impact factor: 4.190